The Helicobacter pylori Neutrophil Activating Protein (HP-NAP) is endowed with immunomodulatory properties that make it a potential candidate for anticancer therapeutic applications.
Publications
FDA’s Approval of New Keytruda Indication Yields Fresh Treatment Option for ‘Gigantic Group of Patients’ With Melanoma
The FDA’s recent greenlight of a new Keytruda indication gives a large group of patients with melanoma access to a treatment option that they didn’t previously have, says an expert from the UPMC Hillman Cancer Center.
Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: A retrospective study
In acral melanoma (AM) cases, ulceration was identified to be an independent negative prognostic factor but the impact differed across Breslow thicknesses and clinical stages.
Bladder tumour as a first manifestation of metastatic choroid melanoma
Incidence of melanoma has been increasing, being able to metastasize to any organ with variable clinical presentation and evolution.